(Q33448329)
Statements
1 reference
Phase I trial and clinical pharmacological evaluation of hexamethylene bisacetamide administration by ten-day continuous intravenous infusion at twenty-eight-day intervals (English)
1 reference
Young CW
1 reference
Fanucchi MP
1 reference
Declan Walsh T
1 reference
Baltzer L
1 reference
Yaldaei S
1 reference
Stevens YW
1 reference
Gordon C
1 reference
Tong W
1 reference
Rifkind RA
1 reference
Marks PA
1 reference
1 December 1988
1 reference
1 reference